Lindeberg H, Krogdahl A
Department of Maxillo-Facial Surgery and Oral Pathology, Royal Dental College, Aarhus University, Denmark.
Cancer Lett. 1999 Nov 1;146(1):9-13. doi: 10.1016/s0304-3835(99)00210-4.
Thirty laryngeal carcinomas from patients without pre-existing laryngeal papillomatosis were examined by PCR for the presence of HPV DNA. The utmost care was taken during sectioning of the tissue blocks and DNA-extraction in order to avoid false positive results. Three pairs of consensus primers were used: MY9/MY11, GP5+/GP6+ and CPI/CPII. HPV was detected in 1/30 carcinomas. The HPV type present could not be determined, but it was not type 6, 11, 13, 16, 18, 30, 31, 33, 35 or 45. In other studies the reported frequency of HPV in laryngeal carcinomas, as estimated by PCR, varies between 3-85%. The reasons for this unacceptable variation in reported results are discussed. The present results indicate that HPV DNA does not have a major role in malignant tumours of the larynx in patients without pre-existing recurrent laryngeal papillomatosis.
对30例无喉乳头状瘤病史患者的喉癌组织进行PCR检测,以确定是否存在HPV DNA。在组织块切片和DNA提取过程中格外小心,以避免出现假阳性结果。使用了三对共有引物:MY9/MY11、GP5+/GP6+和CPI/CPII。在30例癌组织中检测到1例HPV。所发现的HPV类型无法确定,但不是6、11、13、16、18、30、31、33、35或45型。在其他研究中,通过PCR估计的喉癌中HPV的报告频率在3%-85%之间。讨论了报告结果中这种不可接受的差异的原因。目前的结果表明,在无复发性喉乳头状瘤病史的患者中,HPV DNA在喉恶性肿瘤中不起主要作用。